Avi Galler, MD
Colon & Rectal Surgery · Voorhees, NJNPI 1538377726
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Davol Inc. at 56.7% of the total. 2025 is the largest year on record at $961, 9.9 times the $97 reported in 2019.
Across 17 payments — averaging $171.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$2K
- Innocoll Pharmaceuticals Limited$750
- Baxter Healthcare$318
- Intuitive Surgical$114
- Pacira Pharmaceuticals Incorporated$22
- Solventum Corporation$16
- plus $39 from 3 others
What the payments were for
- Consulting fees$75026%
- Speaking & faculty fees$1,65057%
- Food & beverage$42915%
- Education$803%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 2 | $1,650 |
| Innocoll Pharmaceuticals Limited | 1 | $750 |
| Baxter Healthcare | 7 | $318 |
| Intuitive Surgical | 2 | $114 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Solventum Corporation | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Convatec Inc. | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,909 in reported general payments places this provider in the 60th percentile of 86 colon & rectal surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 47 | $221 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $145 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $91 |
| Metronidazole | 48 | $79 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Voorhees
- Deirdre DulakVoorhees$3K
- Keith MeslinVoorhees$2K
- Edwin EmpaynadoVoorhees$453
- Steven Lee-KongHackensack$55K
- Ashlee Godshalk RugglesPennington$44K
- John BerryPennington$36K
- Thomas LakeOakhurst$15K
- Glenn ParkerOakhurst$14K
- Daniel FeingoldNew Brunswick$14K
- Kulvir NandraGlen Ridge$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.